Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients with Psoriasis who had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s431. https://doi.org/10.25251/skin.8.supp.431